| Trial | Updated / Type |
Status | Phase | Were Results Reported |
Reported Actual Enrollment |
(MeSH) Terms |
Why Stopped
Limitations And Caveats |
Annotator decisions |
|---|---|---|---|---|---|---|---|---|
| NCT03163784 Details | 2018-11-15 Interventional | 1/2 | 0 | Anti-Bacterial … Antibiotics, An… Dysbiosis Inflammation HIV/AIDS | The study closed because of shifting research priorities and interests. - | |||
| NCT00310388 2006-000956-42 Details | 2018-11-15 Interventional | 3 | 376 | Ezogabine Epilepsy | No longer any benefit in collecting data since retigabine has been withdrawn from market. - | |||
| NCT03161041 Details | 2018-11-14 Interventional | 2 | 0 | Bevacizumab Oxaliplatin Carcinoma Colorectal Carc… | CHU Lyon will join as a participating center (and as national French coordinator) as a part of
the BEV-IP study ongoing study EudraCT-number 2014-004257-14. - | |||
| NCT02596334 Details | 2018-11-13 Interventional | 3 | 158 | Abacavir Dolutegravir Lamivudine HIV | 5 patients on tivicay had virological failure - | |||
| NCT02268825 Details | 2018-11-13 Interventional | 1 | 39 | Pembrolizumab Gastrointestina… Advanced GI Can… | Merck requested to change MK-3475 dosing schedule; PI decided to close instead - | |||
| NCT01630564 Details | 2018-11-13 Interventional | 1 | 2 | Aldesleukin Interleukin-2 Hematologic Neo… Hematopoietic a… | - - | |||
| NCT00102622 NCT02157870 Details | 2018-11-13 Interventional | 1 | 18 | Paclitaxel Carcinoma, Ovar… Ovarian Neoplas… Ovarian Cancer | Phase I/II study that did not progress to Phase II - | |||
| NCT01740947 2011-002211-28 Details | 2018-11-09 Interventional | 4 | 485 | Amphotericin B Colistin Liposomal ampho… Tobramycin Colorectal Neop… Colorectal Canc… | Superiority was no longer attainable - | |||
| NCT00791271 NCT02605473 Details | 2018-11-09 Interventional | 1 | 17 | Decitabine Interferon alph… Interferon-alph… Interferons Peginterferon a… Melanoma | - - | |||
| NCT00734526 Details | 2018-11-09 Interventional | 1 | 18 | Sorafenib Temozolomide Glioblastoma Gliosarcoma | - - | |||
| NCT00895960 NCT02661113 Details | 2018-11-08 Interventional | 1 | 16 | Dasatinib Temozolomide Brain Diseases Central Nervous… Glioblastoma CNS Disease | Sponsor withdrew support; Study did not progress to Phase II. - | |||
| NCT01855724 2012-001705-24 Details | 2018-11-07 Interventional | 2 | 29 | Gemcitabine Carcinoma Cholangiocarcin… Gallbladder Neo… Biliary Carcino… Gallbladder Car… | - - | |||
| NCT01155479 2009-013552-72 Details | 2018-11-07 Interventional | 3 | [1 Refs] | 1022 | Rasagiline Parkinson Disea… | Termininated for business reasons - | ||
| NCT00693472 Details | 2018-11-07 Interventional | 2 | 46 | Cholinergic Ant… Haloperidol Haloperidol dec… Propranolol Akathisia, Drug… Movement Disord… Psychomotor Agi… Antipsychotic A… | - The study was terminated early by the sponsor due to lack of enrollment. | |||
| NCT00083772 Details | 2018-11-07 Interventional | 4 | 9 | Natriuretic Pep… Cardiovascular … Heart Diseases Heart Failure Heart Failure, … Acute Heart Fai… Cardiovascular … Congestive Hear… Diastolic Heart… Heart Disease | - - | |||
| NCT01215227 2009-015162-57 Details | 2018-11-06 Interventional | 3 | 839 | Rasagiline Parkinson Disea… Idiopathic Park… | - This study was terminated early due to the lack of efficacy of preladenant in the parent studies NCT1155466 and NCT01227265. | |||
| NCT02652156 Details | 2018-11-02 Interventional | 3 | 14 | Bupivacaine Ropivacaine Pain, Postopera… | Operational barriers at the site. - | |||
| NCT00758368 Details | 2018-11-02 Interventional | 2 | 0 | Apomorphine Parkinson Disea… Parkinson's Dis… | Inadequate support to conduct the study - | |||
| NCT00197145 Details | 2018-11-02 Interventional | 3 | 24 | Aplaviroc Acquired Immuno… HIV Infections Infection, Huma… | - Study was early terminated prior to the completion of enrollment due to treatment-emergent hepatotoxicity that occurred among some participants receiving APL. | |||
| NCT00037882 Details | 2018-11-01 Interventional | 2 | 1 | Interferon alph… Interferon-alph… Interferons Peginterferon a… Leukemia Leukemia, Myelo… Leukemia, Myelo… Leukemia, Myelo… | - - |